Holen Sie sich die Stockscreener-App
42.65
0.97%
0.41
Schlusskurs vom Vortag:
$42.24
Offen:
$42.09
24-Stunden-Volumen:
735.82K
Relative Volume:
0.56
Marktkapitalisierung:
$9.22B
Einnahmen:
$1.98B
Nettoeinkommen (Verlust:
$83.59M
KGV:
114.04
EPS:
0.374
Netto-Cashflow:
$502.31M
1W Leistung:
+1.89%
1M Leistung:
+2.92%
6M Leistung:
+0.47%
1J Leistung:
-9.84%
1-Tages-Spanne:
$41.94
$42.66
1-Wochen-Bereich:
$41.11
$43.05
52-Wochen-Spanne:
$37.74
$49.30
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
42.65 | 9.05B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
412.06 | 152.18B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.11 | 135.78B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
518.10 | 39.54B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.77 | 30.49B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
142.82 | 25.78B | 15.50B | 1.33B | 2.16B | 7.34 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Here's Why Qiagen (QGEN) is a Strong Momentum Stock - Yahoo Finance
Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance
Qiagen Stock Beats Earnings, But Its Expensive Valuation Caps Upside Potential (NYSE:QGEN) - Seeking Alpha
Some Investors May Be Willing To Look Past Qiagen's (NYSE:QGEN) Soft Earnings - Yahoo Finance
BlackRock Increases Stake in Qiagen, Influencing Market Dynamics - TipRanks
Qiagen Receives Significant Voting Rights Notification from AFM - TipRanks
Qiagen’s Voting Rights Announcement Highlights BlackRock’s Influence - TipRanks
QIAGEN acquires AI-powered software, Genoox - MSN
Qiagen Releases Q1 2025 Financial Report Highlighting Asset Decline - TipRanks
Pluri (NASDAQ:PLUR) & Qiagen (NYSE:QGEN) Head to Head Contrast - Defense World
Qiagen (QGEN) Expands Genomic Capabilities with Genoox Acquisiti - GuruFocus
QIAGEN Stock Gains Following the Acquisition of Genoox - Zacks Investment Research
PTA-CMS: QIAGEN N.V.: Release of a capital market information - TradingView
Qiagen Acquires Genoox for $70 Million - marketscreener.com
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software - 01net
QIAGEN acquires Genoox to enhance genetic data analysis By Investing.com - Investing.com India
QIAGEN acquires Genoox to enhance genetic data analysis - Investing.com Australia
Qiagen Acquires Genoox For $70 Million Plus $10 Million In Milestones - marketscreener.com
Qiagen (NYSE:QGEN) Shares Sold by First Trust Advisors LP - Defense World
Analysts Are Updating Their Qiagen N.V. (NYSE:QGEN) Estimates After Its First-Quarter Results - simplywall.st
Is Qiagen (NYSE:QGEN) A Risky Investment? - simplywall.st
The Qiagen N.V. (NYSE:QGEN) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
Qiagen N.V. (NYSE:QGEN) Q1 2025 Earnings Call Transcript - Insider Monkey
QIAGEN Reports Strong Q1 2025 Results and Plans Dividend Initiation - TipRanks
QIAGEN NV : UBS sticks Neutral - marketscreener.com
Qiagen (NYSE:QGEN) Upgraded at StockNews.com - Defense World
QIAGEN Reports Strong Q1 2025 Earnings - TipRanks
Qiagen: Good start to 2025 - marketscreener.com
Tissue Diagnostics Market to Reach $12.4 Billion by 2029, Growing at 7.0% CAGR - GlobeNewswire Inc.
QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up - TradingView
QIAGEN NV : Gets a Buy rating from Deutsche Bank - marketscreener.com
Qiagen: Q1 Earnings Snapshot - Norwalk Hour
QiagenH. Rusckowski To Succeed Lawrence A. Rosen As Chairman Of Supervisory Board Following AGM - marketscreener.com
QIAGEN announces plans for transition in leadership of Supervisory Board - BioSpace
Qiagen N : QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase - marketscreener.com
Qiagen N : QIAGEN announces plans for transition in leadership of Supervisory Board - marketscreener.com
QIAGEN announces plans for transition in leadership of Superviso - GuruFocus
QIAGEN (QGEN) Surpasses Q1 Revenue Forecasts, Highlights Strateg - GuruFocus
Stephen Rusckowski to Take Over as Chairman at Qiagen (QGEN) | Q - GuruFocus
Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings - Yahoo Finance
Qiagen NV reports results for the quarter ended March 31Earnings Summary - TradingView
QIAGEN delivers solid Q1 2025 results exceeding outlook; will se - GuruFocus
Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Qiagen board to elect Rusckowski chairman - TipRanks
Qiagen Q1 Adjusted Earnings, Revenue Rise; New $500 Million Stock Buyback Planned - marketscreener.com
QIAGEN (QGEN) Surpasses Q1 Revenue Forecasts, Highlights Strategic Growth | QGEN Stock News - GuruFocus
Stephen Rusckowski to Take Over as Chairman at Qiagen (QGEN) | QGEN Stock News - GuruFocus
Qiagen (QGEN) Announces Supervisory Board Transition - StreetInsider
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase - Business Wire
QIAGEN to propose annual cash dividend for shareholder vote By Investing.com - Investing.com South Africa
QIAGEN to Propose Initiation of Annual Cash Dividend for Shareho - GuruFocus
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):